company background image
000950 logo

C.Q. Pharmaceutical Holding SZSE:000950 Stock Report

Last Price

CN¥6.54

Market Cap

CN¥11.3b

7D

8.6%

1Y

33.5%

Updated

22 Dec, 2024

Data

Company Financials +

C.Q. Pharmaceutical Holding Co., Ltd.

SZSE:000950 Stock Report

Market Cap: CN¥11.3b

My Notes

Capture your thoughts, links and company narrative

C.Q. Pharmaceutical Holding Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for C.Q. Pharmaceutical Holding
Historical stock prices
Current Share PriceCN¥6.54
52 Week HighCN¥6.67
52 Week LowCN¥4.28
Beta0.42
1 Month Change18.26%
3 Month Change40.04%
1 Year Change33.47%
3 Year Change31.59%
5 Year Change16.16%
Change since IPO-34.99%

Recent News & Updates

Is C.Q. Pharmaceutical Holding (SZSE:000950) A Risky Investment?

Dec 03
Is C.Q. Pharmaceutical Holding (SZSE:000950) A Risky Investment?

C.Q. Pharmaceutical Holding's (SZSE:000950) Returns On Capital Not Reflecting Well On The Business

Nov 12
C.Q. Pharmaceutical Holding's (SZSE:000950) Returns On Capital Not Reflecting Well On The Business

C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares

Oct 25
C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares

Recent updates

Is C.Q. Pharmaceutical Holding (SZSE:000950) A Risky Investment?

Dec 03
Is C.Q. Pharmaceutical Holding (SZSE:000950) A Risky Investment?

C.Q. Pharmaceutical Holding's (SZSE:000950) Returns On Capital Not Reflecting Well On The Business

Nov 12
C.Q. Pharmaceutical Holding's (SZSE:000950) Returns On Capital Not Reflecting Well On The Business

C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares

Oct 25
C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares

Is C.Q. Pharmaceutical Holding (SZSE:000950) Using Too Much Debt?

Jul 13
Is C.Q. Pharmaceutical Holding (SZSE:000950) Using Too Much Debt?

C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares

Jun 11
C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) Doing What It Can To Lift Shares

Does C.Q. Pharmaceutical Holding (SZSE:000950) Have A Healthy Balance Sheet?

Mar 28
Does C.Q. Pharmaceutical Holding (SZSE:000950) Have A Healthy Balance Sheet?

Shareholder Returns

000950CN HealthcareCN Market
7D8.6%-2.2%-1.2%
1Y33.5%-7.7%11.8%

Return vs Industry: 000950 exceeded the CN Healthcare industry which returned -7.7% over the past year.

Return vs Market: 000950 exceeded the CN Market which returned 11.8% over the past year.

Price Volatility

Is 000950's price volatile compared to industry and market?
000950 volatility
000950 Average Weekly Movement6.1%
Healthcare Industry Average Movement8.3%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 000950 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 000950's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199914,485Wei Liuwww.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. distributes pharmaceutical products. The company engages in the research, development, production, and investment for medical device in the pharmaceutical industry. It offers medicines, medical devices, Chinese herbal medicines, health care products, hospital sales, and commercial wholesale, retail chain; terminal distribution; warehousing logistics; and supply chain value-added services.

C.Q. Pharmaceutical Holding Co., Ltd. Fundamentals Summary

How do C.Q. Pharmaceutical Holding's earnings and revenue compare to its market cap?
000950 fundamental statistics
Market capCN¥11.30b
Earnings (TTM)CN¥429.57m
Revenue (TTM)CN¥81.43b

26.3x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000950 income statement (TTM)
RevenueCN¥81.43b
Cost of RevenueCN¥75.47b
Gross ProfitCN¥5.96b
Other ExpensesCN¥5.53b
EarningsCN¥429.57m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.25
Gross Margin7.31%
Net Profit Margin0.53%
Debt/Equity Ratio154.2%

How did 000950 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

32%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 10:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

C.Q. Pharmaceutical Holding Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Feifei XuChina Merchants Securities Co. Ltd.
Tielin ChenTopsperity Securities
Xinming ZhouTopsperity Securities